These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 2527097)

  • 1. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
    Hechtman P; Boulay B; Bayleran J; Andermann E
    Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
    Bayleran J; Hechtman P; Kolodny E; Kaback M
    Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
    Hechtman P; Khoo K; Isaacs C
    Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.
    Trop I; Kaplan F; Brown C; Mahuran D; Hechtman P
    Hum Mutat; 1992; 1(1):35-9. PubMed ID: 1301189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
    Bayleran J; Hechtman P; Saray W
    Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.
    Petroulakis E; Cao Z; Clarke JT; Mahuran DJ; Lee G; Triggs-Raine B
    Hum Mutat; 1998; 11(6):432-42. PubMed ID: 9603435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
    Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
    Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A.
    Navon R; Kopel R; Nutman J; Frisch A; Conzelmann E; Sandhoff K; Adam A
    Am J Hum Genet; 1985 Jan; 37(1):138-46. PubMed ID: 3156493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active arginine residues in beta-hexosaminidase. Identification through studies of the B1 variant of Tay-Sachs disease.
    Brown CA; Mahuran DJ
    J Biol Chem; 1991 Aug; 266(24):15855-62. PubMed ID: 1831451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A shortened beta-hexosaminidase alpha-chain in an Italian patient with infantile Tay-Sachs disease.
    Zokaeem G; Bayleran J; Kaplan P; Hechtman P; Neufeld EF
    Am J Hum Genet; 1987 Jun; 40(6):537-47. PubMed ID: 2954459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two abnormalities of hexosaminidase A in clinically normal individuals.
    Grebner EE; Mansfield DA; Raghavan SS; Kolodny EH; d'Azzo A; Neufeld EF; Jackson LG
    Am J Hum Genet; 1986 Apr; 38(4):505-14. PubMed ID: 2939713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tay-Sachs disease: B1 variant.
    Gordon BA; Gordon KE; Hinton GG; Cadera W; Feleki V; Bayleran J; Hechtman P
    Pediatr Neurol; 1988; 4(1):54-7. PubMed ID: 2976595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K
    Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A; Holding J; Carey WF
    Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis.
    Lemieux MJ; Mark BL; Cherney MM; Withers SG; Mahuran DJ; James MN
    J Mol Biol; 2006 Jun; 359(4):913-29. PubMed ID: 16698036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new point mutation (G412 to A) at the last nucleotide of exon 3 of hexosaminidase alpha-subunit gene affects splicing.
    Ozkara HA; Sandhoff K
    Brain Dev; 2003 Apr; 25(3):203-6. PubMed ID: 12689701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic cause of a juvenile form of Tay-Sachs disease in a Lebanese child.
    Boustany RM; Tanaka A; Nishimoto J; Suzuki K
    Ann Neurol; 1991 Jan; 29(1):104-7. PubMed ID: 1996872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
    Myerowitz R
    Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
    Peleg L; Goldman B
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
    Inui K; Grebner EE; Jackson LG; Wenger DA
    Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.